Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Guideline on the management of bleeding in patients on antithrombotic agents.

Makris M, Van Veen JJ, Tait CR, Mumford AD, Laffan M; British Committee for Standards in Haematology..

Br J Haematol. 2013 Jan;160(1):35-46. doi: 10.1111/bjh.12107. Epub 2012 Nov 1. No abstract available.

PMID:
23116425
2.

Management of bleeding in patients on antithrombotics: maintaining the balance between thrombosis and hemorrhage.

Crowther M, Crowther M.

Expert Rev Hematol. 2009 Aug;2(4):357-60. doi: 10.1586/ehm.09.37. No abstract available.

PMID:
21082940
3.

Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.

Nieuwlaat R, Olsson SB, Lip GY, Camm AJ, Breithardt G, Capucci A, Meeder JG, Prins MH, Lévy S, Crijns HJ; Euro Heart Survey Investigators..

Am Heart J. 2007 Jun;153(6):1006-12.

PMID:
17540203
4.

Endoscopy in the patient on antithrombotic therapy.

Abu Daya H, Younan L, Sharara AI.

Curr Opin Gastroenterol. 2012 Sep;28(5):432-41. doi: 10.1097/MOG.0b013e328355e26f. Review.

PMID:
22885943
5.

Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndrome.

Van de Werf F.

Circulation. 2010 Jan 5;121(1):5-7. doi: 10.1161/CIR.0b013e3181cd3d17. Epub 2009 Dec 21. No abstract available. Erratum in: Circulation. 2010 Jun 29;121(25):e462.

6.

Conflicting clinical environment about the management of antithrombotic agents during the periendoscopic period in Japan.

Ono S, Fujishiro M, Kanzaki H, Uedo N, Yokoi C, Akiyama J, Sugawara M, Oda I, Suzuki S, Fujita Y, Tsubata S, Hirano M, Fukuzawa M, Kataoka M, Kamoshida T, Hirai S, Sumiyoshi T, Kondo H, Yamamoto Y, Okada K, Morita Y, Fujiwara S, Morishita S, Matsumoto M, Koike K.

J Gastroenterol Hepatol. 2011 Sep;26(9):1434-40. doi: 10.1111/j.1440-1746.2011.06761.x.

PMID:
21557769
7.

Management of bleeding in patients taking FXa and FIIa inhibitors.

Keeling D, Cotter F.

Br J Haematol. 2013 Jan;160(1):1-2. doi: 10.1111/bjh.12106. Epub 2012 Oct 30. No abstract available.

PMID:
23110431
8.

Determinants of bleeding risk in patients on antithrombotic and antifibrinolytic drugs.

Meijer K, Schulman S.

Semin Thromb Hemost. 2008 Nov;34(8):762-71. doi: 10.1055/s-0029-1145258. Epub 2009 Feb 12. Review.

PMID:
19214914
9.

[The antithrombotic-treated patient].

Nielsen JD, Rasmussen HM, Husted SE.

Ugeskr Laeger. 2006 Dec 4;168(49):4296-9. Danish.

PMID:
17164056
10.

Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.

Spyropoulos AC, Douketis JD.

Int Angiol. 2008 Aug;27(4):333-43. No abstract available.

PMID:
18677297
11.

[Antithrombotic drugs in women: should we worry more about bleeding?].

Abbate R, Cioni G, Marcucci R, Fatini C, Gensini GF.

G Ital Cardiol (Rome). 2012 Jun;13(6):407-13. doi: 10.1714/1073.11758. Italian.

PMID:
22622119
12.

Is early antithrombotic therapy necessary after tissue mitral valve replacement?

Colli A, D'Amico R, Mestres CA, Pomar JL, Cámara ML, Ruyra X, Mulet J.

J Heart Valve Dis. 2010 Jul;19(4):405-11.

PMID:
20845885
13.

Evaluation of safety of endoscopic biopsy without cessation of antithrombotic agents in Japan.

Ono S, Fujishiro M, Kodashima S, Takahashi Y, Minatsuki C, Mikami-Matsuda R, Asada-Hirayama I, Konno-Shimizu M, Tsuji Y, Mochizuki S, Niimi K, Yamamichi N, Kaneko M, Yatomi Y, Koike K.

J Gastroenterol. 2012 Jul;47(7):770-4. doi: 10.1007/s00535-012-0538-7. Epub 2012 Feb 18.

PMID:
22350697
14.

Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The Bleeding with Antithrombotic Therapy (BAT) Retrospective Study.

Toyoda K, Yasaka M, Nagata K, Nagao T, Gotoh J, Sakamoto T, Uchiyama S, Minematsu K; Bleeding with Antithrombotic Therapy Study Group..

Cerebrovasc Dis. 2009;27(2):151-9. doi: 10.1159/000177924. Epub 2008 Nov 28.

PMID:
19039219
15.

Antithrombotic treatment in patients with unstable coronary artery disease undergoing CABG.

Stahle E, Lindahl B.

Ann Thorac Surg. 2001 May;71(5):1748-9. No abstract available.

PMID:
11383850
16.

Percutaneous left atrial appendage closure with minimal antithrombotic treatment in patients at very high risk of bleeding events.

Lund J, Saraste A, Airaksinen KE.

Thromb Res. 2012 Sep;130(3):e194-5. doi: 10.1016/j.thromres.2012.05.013. Epub 2012 Jun 8. No abstract available.

PMID:
22682609
17.

Compliance with antithrombotic guidelines in surgery patients in German hospitals: a multicenter study involving pharmacy interns.

Hohmann C, Eickhoff C, Kaemmerer W, Schulz M.

Clin Appl Thromb Hemost. 2012 Jun;18(3):299-304. doi: 10.1177/1076029611412368. Epub 2011 Jul 6.

PMID:
21733934
18.

Bleeding after antithrombotic therapy in patients with acute ischemic heart disease: is it the drugs or how we use them?

Cohen M, Alexander KP, Rao SV.

J Thromb Thrombolysis. 2008 Dec;26(3):175-82. Epub 2007 Dec 15.

PMID:
18080799
19.

A prospective evaluation of bleeding risk of interventional techniques in chronic pain.

Manchikanti L, Malla Y, Wargo BW, Cash KA, McManus CD, Damron KS, Jackson SD, Pampati V, Fellows B.

Pain Physician. 2011 Jul-Aug;14(4):317-29.

20.

[Dental treatment and anti-thrombotic therapy. Part 1: clinical guideline].

Sachar Helft S, Chackartchi T, Findler M.

Refuat Hapeh Vehashinayim (1993). 2013 Oct;30(4):6-11, 74. Hebrew.

PMID:
24660571

Supplemental Content

Support Center